The Sahlgrenska University Hospital is a hospital network associated with the Sahlgrenska Academy at the University of Gothenburg in Gothenburg, Sweden. With 17,000 employees the hospital is the largest hospital in Sweden by a considerable margin, and the second largest hospital in Europe.

There are 2,000 beds in Dept. of Surgery, Sahlgrenska University Hospital/Ostra.

During the past decade, Dept. of Surgery, Sahlgrenska University Hospital/Ostra conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dept. of Surgery, Sahlgrenska University Hospital/Ostra" #1 collaborator was "Sahlgrenska University Hospital, Sweden" with 4 trials as a collaborator, "Högskolan Väst" with 2 trials as a collaborator, "Swedish Cancer Foundation" with 2 trials as a collaborator, "The Göteborg Medical Society, Sweden" with 2 trials as a collaborator and "Göteborg University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Dept. of Surgery, Sahlgrenska University Hospital/Ostra" are "Colorectal Cancer" (3 trials), "Rectal Cancer" (3 trials), "Rectal Neoplasms" (3 trials), "Anal Cancer" (2 trials) and "Colorectal Neoplasms" (2 trials). Many other conditions were trialed in "Dept. of Surgery, Sahlgrenska University Hospital/Ostra" in a lesser frequency.

Most popular intervention types in "Dept. of Surgery, Sahlgrenska University Hospital/Ostra" are "Other" (9 trials), "Procedure" (7 trials), "Drug" (4 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Active observation" (1 trials), "Alginate" (1 trials), "Antibiotic treatment (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3)." (1 trials) and "CT or PET scans" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept. of Surgery, Sahlgrenska University Hospital/Ostra" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Dept. of Surgery, Sahlgrenska University Hospital/Ostra". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Dept. of Surgery, Sahlgrenska University Hospital/Ostra, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dept. of Surgery, Sahlgrenska University Hospital/Ostra, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".